MGMT and glioblastoma: Taken together, PRIMA-1MET decreased relative cell numbers and disrupted the morphology and structure of neurospheres in a time- and dose- dependent manner in both MGMT-positive and –negative wtp53 GSCs at lower doses than in GBM established cell lines.